Deepak Chemtex Ltd

Deepak Chemtex Ltd – Closure of Trading Window from October 01, 2026 in connection with unaudited financial results for the half year ending September 30, 2026; Trading Window will open 48 hours after the said financial results are declared to the Stock Exchange.

AGM Details

• AGM held on 21 September 2026 at 12:30 PM via VC/OAVM.
• Meeting ended at 1:15 PM.
• Record date for shareholders: 14 September 2026.
• Five resolutions were presented for voting.

Key Resolutions

• Ordinary: Adoption of audited standalone and consolidated financial statements for year ended March 31, 2026.
• Ordinary: Re-appointment of director by rotation—Saurabh Deepak Arora.
• Special: Re-appointment of Saurabh Deepak Arora as Chairman and Managing Director.
• Special: Re-appointment of Mrs. Trishla Baid Arora as Whole-Time Director.
• Ordinary: Approval of material related party transaction with DCPL Speciality Chemicals Private Limited (subsidiary).

Voting Results

• Resolution 1 passed with 100% in favour; no dissent.
• Resolution 2 passed with 100% in favour; no dissent.
• Resolution 3 passed with 100% in favour; no dissent.
• Resolution 4 passed with 100% in favour; no dissent.
• Resolution 5 approved; 88.64% in favour, 11.36% against (42,240 valid votes).

Director Changes

• Saurabh Deepak Arora re-appointed as Director by rotation.
• Saurabh Deepak Arora re-appointed as Chairman and Managing Director.
• Mrs. Trishla Baid Arora re-appointed as Whole-Time Director.

Material Related Party Transactions

• Approval of related party transaction with DCPL Speciality Chemicals Private Limited (subsidiary).

AGM Details

• AGM held Sep 21, 2026 at 12:30 p.m. via VC/OAVM; concluded 01:15 p.m.
• Remote e-voting window Sep 18-20, 2026; cut-off date Sep 14, 2026.
• Quorum of seven members; meeting declared duly constituted.
• Notice and annual report circulated electronically; available on company and stock exchange websites.

Key Resolutions

• Ordinary: Adopt standalone and consolidated financial statements for FY2025-26.
• Ordinary: Re-appoint director Saurabh Deepak Arora, retires by rotation.
• Special: Re-appointment of Saurabh Deepak Arora as Chairman and Managing Director.
• Special: Re-Appointment of Mrs. Trishla Baid Arora as Whole Time Director.
• Ordinary: Approval of Material Related Party Transaction with DCPL Speciality Chemicals Private Limited.

Voting Status

• Voting results for all resolutions pending; to be declared within prescribed timelines.

AGM notice and access

• 29th AGM to be held on 21 September 2026 at 12:30 PM IST via VC/OAVM.
• Cut-off date for voting set at 14 September 2026.
• Voting window opens 18 September 2026 at 09:00 AM and closes 20 September 2026 at 05:00 PM.
• Notice and Integrated Annual Report for 2025-26 available at company website.
• Notice also available on BSE and NSDL websites; letters sent to shareholders without registered emails.

Standalone financials

• Standalone revenue from operations FY2026: ₹5,349.61 lakh, down from FY2025.
• Standalone total income FY2026: ₹5,648.61 lakh versus ₹7,050.35 lakh FY2025.
• Standalone PAT after tax FY2026: ₹659.25 lakh, vs ₹1,006.95 lakh FY2025.
• Standalone basic EPS: ₹6.07; diluted EPS: ₹6.07.
• Dividend for FY2025-26: not declared.
• Standalone credit metrics show improved liquidity but lower profitability year-on-year.

Consolidated performance

• Consolidated revenue FY2026: ₹7,062.88 lakh; FY2025: ₹8,195.37 lakh.
• Consolidated PAT attributable to owners FY2026: ₹846.88 lakh; FY2025: ₹1,250.92 lakh.
• Consolidated EPS: ₹7.80 for FY2026; ₹11.51 for FY2025.
• Consolidated revenue from operations FY2026: ₹6,763.87 lakh.
• Consolidated cash flow from operations FY2026: ₹625.70 lakh.
• DSCR (months) FY2026: 37.03; FY2025: 48.52.

Capital structure & liquidity

• Debt-to-equity ratio: 0.01x in FY2026 (vs 0.02x in FY2025).
• Standalone long-term borrowings: ₹49.06 lakh; short-term borrowings: ₹21.02 lakh.
• Standalone equity: ₹6,012.04 lakh; reserves: ₹4,925.64 lakh.
• Current ratio FY2026: 4.45x.

Governance & board

• Saurabh Deepak Arora reappointed as Chairman & MD for 3 years from 28 Jul 2026.
• Trishla Baid Arora reappointed as Whole-time Director for 3 years from 28 Jul 2026.
• Ms. Sonam Sharma resigned as Company Secretary & Compliance Officer w.e.f 17 Aug 2026.
• Board size six; independent directors declared independence; 2025 changes noted.

Related party transactions

• Material RPT with DCPL Speciality Chemicals Private Limited; cap ₹50 crore; arm's length.
• FY2026 related party sales to DCPL: ₹720.49 lakh; to South West Corporation: ₹1,071.49 lakh.
• Loans to DCPL: ₹2,249.12 lakh; Atlas Tints: ₹1.13 lakh; SW Corporation: ₹0.02 lakh.
• Remuneration paid from related parties: ₹60.00 lakh to Saurabh Arora; ₹41.75 lakh to Trishla Arora.

CSR & sustainability

• CSR expenditure for FY2025-26: ₹21.00 lakh; mandated ₹21.71 lakh.
• Average net profit for last three years: ₹1,036.29 lakh.
• CSR policy and CSR committee disclosed on company website.

Audit & controls

• Statutory auditors M/s Mital & Associates issued an unqualified report.
• Secretarial audit by NKM & Associates; overseas APR filings noted; not all items flagged.
• Internal controls over financial reporting deemed adequate; audit trails maintained in software.

Outlook & strategic focus

• Management aims to expand speciality chemicals portfolio and manufacturing capacity.
• Grow international presence; focus on energy efficiency and cost optimization.
• Sustained growth through diversified product applications and customer-centric innovation.

AGM Details

• AGM date and time: September 21, 2026, at 12:30 PM IST; mode: VC/OAVM.
• Record date/cut-off: September 14, 2026.
• Remote e-voting window: Sep 18–20, 2026.
• Deemed venue: registered office.

Key Resolutions

• Ordinary: adopt audited standalone and consolidated financial statements for FY 2025-26.
• Ordinary: appoint director by rotation and re-appointment.
• Special: re-appoint Saurabh Deepak Arora as Chairman and MD for 3 years.
• Remuneration for Arora: up to board-approved monthly limit; minimum remuneration.
• Special: re-appoint Trishla Baid Arora as Whole-time Director for 3 years.
• Remuneration for Trishla Arora: up to monthly limit; minimum remuneration.
• Special: approve material related party transactions with DCPL Speciality Chemicals Private Limited.
• Period: up to next AGM; aggregate limit; arm’s-length terms.
• Board authorized to implement and finalize related procedures.

Director Changes

• Saurabh Deepak Arora re-appointed as Director by rotation.
• Trishla Baid Arora re-appointed as Whole-time Director.
• Termination notice: two months’ notice or two months remuneration in lieu.

Related Party Transactions

• RPTs with DCPL Speciality Chemicals Private Limited disclosed; includes nature and prior transactions.

Key decisions

• Approved Directors' Report along with MD&A for the year ended 31 March 2026 for submission to shareholders.
• Fixed 29th AGM date as 21 September 2026, via VC/OAVM.